DTIL: Precision BioSciences Inc

DTIL News

• Seeking Alpha 14:15 The Play On TG Therapeutics (NASDAQ:TGTX)
• Investing 12:10 Precision BioSciences stock rises after FDA grants orphan drug status
• Investing 11:08 FDA grants orphan drug status to Precision BioSciences’ DMD treatment
• Investing 16:10 Precision BioSciences gets FDA orphan drug designations for DMD treatment
• Investing 11:15 Precision BioSciences reports promising DMD gene editing results
• Investing 10:20 Precision Biosciences director Brown buys $6963 in DTIL stock
• Investing 10:17 Precision Biosciences director Buehler buys $21k in shares
• Seeking Alpha 20:05 TG Therapeutics: Another Possible Avenue Of MS Growth With Azer-Cel (NASDAQ:TGTX)
• Investing 11:17 FDA grants rare pediatric disease status to Precision BioSciences DMD therapy
• Investing 11:13 Precision BioSciences stock jumps after FDA grants rare pediatric designation
• Investing 11:19 precision biosciences reports voting outcomes at annual shareholder meeting
• Investing 11:16 Precision BioSciences Reports First Quarter 2025 Financial Results and Provides Business Update
• Seeking Alpha 08:44 CRISPR And Intellia: Balancing Market Uncertainty Against Pipeline Catalysts (NASDAQ:CRSP)
• Benzinga 11:40 Why Precision BioSciences Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket - Aspira Womens Health (NASDAQ:AWH), Aclarion (NASDAQ:ACON)
• Seeking Alpha 12:42 Precision & TG Therapeutics: Unlocking Value With ARCUS, BRIUMVI And Azer-Cel (NASDAQ:DTIL)
• Benzinga 19:27 Precision BioSciences Touts Encouraging Initial Safety And Antiviral Activity Of Hepatitis B Treatment Candidate - Precision BioSciences (NASDAQ:DTIL)